Summary
Pfizer Inc. (PFE) filed an 8-K report on October 24, 2008, detailing amendments to its By-laws approved by the Board of Directors on October 23, 2008. The most significant change relates to the calling of special meetings of stockholders. Previously, the conditions for calling a special meeting were not explicitly stated in this filing. The amendment now requires a written request from record holders of at least 25% of the total voting shares to compel the Chair of the Board or the Secretary to call such a meeting. These amendments also include conforming changes to other sections of the By-laws, specifically those pertaining to the number of directors, their election and term, and the procedures for director nominations by stockholders. This update to the By-laws may impact shareholder engagement and governance dynamics by potentially making it easier for a significant block of shareholders to convene special meetings for important matters.
Key Highlights
- 1Pfizer's Board of Directors approved amendments to the company's By-laws on October 23, 2008.
- 2The By-laws were amended to change Article I, Section 9 (Special Meetings).
- 3Special stockholder meetings can now be called at the written request of stockholders holding at least 25% of the total voting shares.
- 4This 25% threshold requires a written request to either the Chair of the Board or the Secretary.
- 5Conforming and related changes were made to By-law sections concerning director election, term, and nomination procedures.
- 6The amended By-laws are filed as Exhibit 3.1 to this 8-K report.